| Model Number |
03P6822 |
| Medical Device Problem Code |
High Test Results (2457)
|
| Health Effect - Clinical Code |
No Known Impact Or Consequence To Patient (2692)
|
| Date of Event |
10/14/2020
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
|
| |
|
Event or Problem Description
|
|
The customer reported falsely elevated magnesium results for 3 patients while running on the architect c4000 processing module.The customer was only able to provide discrepant results for one patient.The following data was provided (customer's reference range: 1.3 to 2.1 mg/dl): sid: (b)(6) = initial result = 6.25 mg/dl, repeat = 1.43, 1.4 mg/dl.There was no impact to patient management reported.
|
| |
|
Additional Manufacturer Narrative
|
|
A review of tickets determined that there is normal complaint activity for architect magnesium reagent ln 3p68-32/lot number 85056un20.Trending review identified no trends for discrepant patient results for the product.Return testing was not completed as returns were not available.Worldwide data was reviewed and determined that the patient median result for magnesium reagent lot number 85056un20 is within established control limits.Retesting of the sample gave expected normal results.A review of the manufacturing documentation did not identify any non-conformances or deviations associated with the complaint issue.A review of the product labeling determined that the issue was adequately addressed.Based on the investigation, no systemic issue or deficiency of the architect magnesium reagent lot number 85056un20 was identified.
|
| |
|
Search Alerts/Recalls
|